产品

本公司产品仅供体外研究使用,不用于临床诊断

NRF2, NFE2L2 antibody

别称:HEBP1 antibody, NF E2 related factor 2 antibody, NFE2 related factor 2 antibody, NFE2L2 antibody, NRF2 antibody
货号:FNab05855反应性:Human, Mouse, Rat, Zebrafish
宿主:Rabbit验证实验:ELISA, IP, WB, IHC, FC
克隆性:polyclonal亚型:IgG
¥1900
规格:
货期: 三个工作日+顺丰快递时长
  • 产品介绍
  • 相关文献
产品名称
NRF2, NFE2L2 antibody
货号
FNab05855
规格
100μg
状态
liquid
纯化方法
Immunogen affinity purified
纯度
≥95% as determined by SDS-PAGE
克隆性
polyclonal
亚型
IgG
存储
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.)
免疫原信息
免疫原
nuclear factor(erythroid-derived 2)-like 2
别称
HEBP1 antibody, NF E2 related factor 2 antibody, NFE2 related factor 2 antibody, NFE2L2 antibody, NRF2 antibody
UniProt ID
Q16236
分子量
70-100 kDa
验证实验
验证实验
ELISA, IP, WB, IHC, FC
建议稀释比例
WB: 1:200-1:2000; IP: 1:200-1:1000; IHC: 1:50-1:500
验证图片
DMSO treated HeLa cells were subjected to SDS PAGE followed by western blot with FNab05855(NRF2, NFE2L2 Antibody) at dilution of 1:600
IP Result of anti-NRF2, NFE2L2 (IP: FNab05855, 3ug; Detection: FNab05855 1:300) with mouse kidney tissue lysate 4000ug.
Immunohistochemistry of paraffin-embedded human ovary tumor tissue slide using FNab05855(NRF2, NFE2L2 Antibody) at dilution of 1:200 heat mediated antigen retrieved with Tris-EDTA buffer(pH9).
背景介绍
NRF2, also named as NFE2L2, belongs to the bZIP family and CNC subfamily. It is a transcription activator that binds to antioxidant response(ARE) elements in the promoter regions of target genes. NRF2 is important for the coordinated up-regulation of genes in response to oxidative stress. It may be involved in the transcriptional activation of genes of the beta-globin cluster by mediating enhancer activity of hypersensitive site 2 of the beta-globin locus control region.Nrf2 is a key player in the regulation of genes encoding for many antioxidative response enzymes.The expression of NRF2 may be induced under oxidative stress(PMID:14567983).In lung cancer, Nrf2 activation in malignant cells has been associated with tumor progression and chemotherapy resistance(PMID:20534738). Identifying patients with abnormal NRF2 expression may be important for selection for chemotherapy in NSCLC.